Digital Pharmacy Market Size, Share, Trends, Industry Analysis Report: By Product, Drug Type, Platform, and Region

Description

List of Tables

The digital pharmacy market size is expected to reach USD 483.53 billion by 2032, according to a new study by Polaris Market Research. The report "Digital Pharmacy Market Size, Share, Trends, Industry Analysis Report: By Product, Drug Type, Platform (Application Based and Web Based), and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The digital pharmacy market growth is driven by the increasing demand for convenient healthcare solutions. As consumers seek more accessible and efficient ways to manage their health, digital pharmacies are emerging as a preferred alternative to traditional brick-and-mortar establishments. The rise in online shopping habits, coupled with the desire to avoid long wait times and inconvenient travel, is fueling the shift towards digital platforms. Digital pharmacies offer the convenience of managing prescriptions, accessing medication refills, and receiving health consultations from the comfort of one's home, which aligns with the broader trend towards digitalization in healthcare. Additionally, the integration of user-friendly apps and platforms that provide 24/7 access to pharmaceutical services further enhances the appeal. This trend is not only driven by consumer preferences but also supported by advancements in technology and the growing adoption of telehealth services.

Government support and favorable regulations are anticipated to drive the digital pharmacy market in the forecast years. Policymakers and regulatory bodies are increasingly recognizing the potential of digital health solutions to improve healthcare access and efficiency. This has led to the implementation of supportive policies and frameworks that facilitate the integration of digital pharmacies into the broader healthcare system. For instance, regulations that streamline telehealth services, permit electronic prescriptions, and safeguard patient data are creating a more conducive environment for digital pharmacies to thrive. Additionally, government initiatives aimed at promoting telemedicine and reducing barriers to online healthcare services are further supporting the market. These supportive measures not only enhance the legitimacy and operational ease of digital pharmacies but also encourage investment and innovation in the sector. As a result, the digital pharmacy market benefits from a more structured and regulated environment, which drives its expansion and acceptance among both healthcare providers and patients.

Over-the-counter drugs segment is gaining popularity among the general population. A major portion of patients prefer OTC as the first line of action during minor diseases before consulting with a physician. The increase in OTC drug consumption is a result of increased awareness about disease cures and precaution methods among people.

Digital Pharmacy Market Report Highlights

By drug type analysis, the over-the-counter products segment is anticipated to experience substantial growth with a significant CAGR in the market. This growth is attributed to an increase in the preference for OTC drugs during minor inconveniences before consulting with physicians.

By platform outlook, the application based segment accounted for the largest revenue share of the market in 2023 due to an increase in the number of smartphone users and growing internet connectivity worldwide.

In 2023, North America dominated the digital pharmacy market due to the growing internet users and percentage of the population share with stable internet connection.

The digital pharmacy market in India is projected for substantial growth due to the government's initiatives for e-commerce and the quick-commerce industry.

The key market players are Amazon Pharmacy; CVS Health; Walgreen Co.; Giant Eagle Inc.; Walmart Inc.; Express Scripts Holding Company; Rowlands Pharmacy; Optum Rx Inc.; Axelia Solutions; Apollo Pharmacy; Netmeds.Com; Cigna Corporation; Apex Healthcare Berhad; PharmEasy; Pharmex Direct Inc.; and Rexall Pharmacy Group ULC.

Polaris Market Research has segmented the digital pharmacy market report based on Product, Drug Type, Platform, and region:

By Product Outlook (Revenue - USD billion, 2019-2032)

Medicine & Treatment
Diabetic Care
Heart Care
Oncology
Other
Vitamins & Supplements
Personal Care Products
Others

By Drug Type Outlook (Revenue - USD billion, 2019-2032)

Prescription Medicines
Over-the-counter Products

By Platform Outlook (Revenue - USD billion, 2019-2032)

Application Based
Web Based

By Regional Outlook (Revenue - USD billion, 2019-2032)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of the Middle East & Africa

Product Code: PM2786

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Digital Pharmacy Market Insights

4.1. Digital Pharmacy Market - Market Snapshot
4.2. Digital Pharmacy Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increased Consumer Demand for Convenience Are Driving Market Growth
  - 4.2.1.2. Government Support and Regulations is Propelling Market Size
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Complexity in Logistics
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Digital Pharmacy Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Digital Pharmacy Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
5.3. Medicine & Treatment
- 5.3.1. Global Digital Pharmacy Market, by Medicine & Treatment, by Region, 2019-2032 (USD billion)
- 5.3.2. Diabetic Care
- 5.3.3. Global Digital Pharmacy Market, by diabetic care, by Region, 2019-2032 (USD billion)
- 5.3.4. Heart Care
- 5.3.5. Global Digital Pharmacy Market, by heart care, by Region, 2019-2032 (USD billion)
- 5.3.6. Oncology
- 5.3.7. Global Digital Pharmacy Market, by oncology, by Region, 2019-2032 (USD billion)
- 5.3.8. Other medicine & treatment
- 5.3.9. Global Digital Pharmacy Market, by oncology, by Region, 2019-2032 (USD billion)
5.4. Vitamins & Supplements
- 5.4.1. Global Digital Pharmacy Market, by Vitamins & Supplements, by Region, 2019-2032 (USD billion)
5.5. Personal Care Products
- 5.5.1. Global Digital Pharmacy Market, by Personal Care Products, by Region, 2019-2032 (USD billion)
5.6. Others
- 5.6.1. Global Digital Pharmacy Market, by Others, by Region, 2019-2032 (USD billion)

6. Global Digital Pharmacy Market, by Drug Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
6.3. Prescription Medicines
- 6.3.1. Global Digital Pharmacy Market, by Prescription Medicines, by Region, 2019-2032 (USD billion)
6.4. Over-the-Counter Drugs
- 6.4.1. Global Digital Pharmacy Market, by Over-the-Counter drugs, by Region, 2019-2032 (USD billion)

7. Global Digital Pharmacy Market, by Platform

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
7.3. Application Based
- 7.3.1. Global Digital Pharmacy Market, by application based, by Region, 2019-2032 (USD billion)
7.4. Web Based
- 7.4.1. Global Digital Pharmacy Market, by Ambulatory Surgery Centers, by Region, 2019-2032 (USD billion)

8. Global Digital Pharmacy Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Digital Pharmacy Market Assessment, By Geography, 2019-2032 (USD billion)
8.3. Digital Pharmacy Market - North America
- 8.3.1. North America: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
- 8.3.2. North America: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
- 8.3.3. North America: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.3.4. Digital Pharmacy Market - U.S.
  - 8.3.4.1. U.S.: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.3.4.2. U.S.: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.3.4.3. U.S.: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.3.5. Digital Pharmacy Market - Canada
  - 8.3.5.1. Canada: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.3.5.2. Canada: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.3.5.3. Canada: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
8.4. Digital Pharmacy Market - Europe
- 8.4.1. Europe: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
- 8.4.2. Europe: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
- 8.4.3. Europe: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.4.4. Digital Pharmacy Market - UK
  - 8.4.4.1. UK: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.4.4.2. UK: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.4.4.3. UK: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.4.5. Digital Pharmacy Market - France
  - 8.4.5.1. France: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.4.5.2. France: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.4.5.3. France: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.4.6. Digital Pharmacy Market - Germany
  - 8.4.6.1. Germany: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.4.6.2. Germany: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.4.6.3. Germany: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.4.7. Digital Pharmacy Market - Italy
  - 8.4.7.1. Italy: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.4.7.2. Italy: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.4.7.3. Italy: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.4.8. Digital Pharmacy Market - Spain
  - 8.4.8.1. Spain: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.4.8.2. Spain: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.4.8.3. Spain: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.4.9. Digital Pharmacy Market - Netherlands
  - 8.4.9.1. Netherlands: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.4.9.2. Netherlands: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.4.9.3. Netherlands: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.4.10. Digital Pharmacy Market - Russia
  - 8.4.10.1. Russia: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.4.10.2. Russia: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.4.10.3. Russia: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.4.11. Digital Pharmacy Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.4.11.2. Rest of Europe: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.4.11.3. Rest of Europe: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
8.5. Digital Pharmacy Market - Asia Pacific
- 8.5.1. Asia Pacific: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
- 8.5.2. Asia Pacific: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
- 8.5.3. Asia Pacific: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.5.4. Digital Pharmacy Market - China
  - 8.5.4.1. China: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.5.4.2. China: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.5.4.3. China: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.5.5. Digital Pharmacy Market - India
  - 8.5.5.1. India: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.5.5.2. India: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.5.5.3. India: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.5.6. Digital Pharmacy Market - Malaysia
  - 8.5.6.1. Malaysia: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.5.6.2. Malaysia: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.5.6.3. Malaysia: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.5.7. Digital Pharmacy Market - Japan
  - 8.5.7.1. Japan: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.5.7.2. Japan: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.5.7.3. Japan: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.5.8. Digital Pharmacy Market - Indonesia
  - 8.5.8.1. Indonesia: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.5.8.2. Indonesia: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.5.8.3. Indonesia: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.5.9. Digital Pharmacy Market - South Korea
  - 8.5.9.1. South Korea: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.5.9.2. South Korea: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.5.9.3. South Korea: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.5.10. Digital Pharmacy Market - Australia
  - 8.5.10.1. Australia: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.5.10.2. Australia: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.5.10.3. Australia: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.5.11. Digital Pharmacy Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.5.11.2. Rest of Asia Pacific: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.5.11.3. Rest of Asia Pacific: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
8.6. Digital Pharmacy Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
- 8.6.2. Middle East & Africa: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
- 8.6.3. Middle East & Africa: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.6.4. Digital Pharmacy Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.6.4.2. Saudi Arabia: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.6.4.3. Saudi Arabia: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.6.5. Digital Pharmacy Market - UAE
  - 8.6.5.1. UAE: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.6.5.2. UAE: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.6.5.3. UAE: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.6.6. Digital Pharmacy Market - Israel
  - 8.6.6.1. Israel: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.6.6.2. Israel: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.6.6.3. Israel: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.6.7. Digital Pharmacy Market - South Africa
  - 8.6.7.1. South Africa: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.6.7.2. South Africa: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.6.7.3. South Africa: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.6.8. Digital Pharmacy Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.6.8.2. Rest of Middle East & Africa: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.6.8.3. Rest of Middle East & Africa: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
8.7. Digital Pharmacy Market - Latin America
- 8.7.1. Latin America: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
- 8.7.2. Latin America: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
- 8.7.3. Latin America: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.7.4. Digital Pharmacy Market - Mexico
  - 8.7.4.1. Mexico: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.7.4.2. Mexico: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.7.4.3. Mexico: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.7.5. Digital Pharmacy Market - Brazil
  - 8.7.5.1. Brazil: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.7.5.2. Brazil: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.7.5.3. Brazil: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.7.6. Digital Pharmacy Market - Argentina
  - 8.7.6.1. Argentina: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.7.6.2. Argentina: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.7.6.3. Argentina: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)
- 8.7.7. Digital Pharmacy Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Digital Pharmacy Market, by Product, 2019-2032 (USD billion)
  - 8.7.7.2. Rest of Latin America: Digital Pharmacy Market, by Drug Type, 2019-2032 (USD billion)
  - 8.7.7.3. Rest of Latin America: Digital Pharmacy Market, by Platform, 2019-2032 (USD billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Amazon Pharmacy
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. CVS Health
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Walgreen Co.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Giant Eagle Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Express Scripts Holding Company
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Rowlands Pharmacy
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Optum Rx Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Axelia Solutions
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Apollo Pharmacy
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Netmeds.com
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Cigna Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Apex Healthcare Berhad
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. PharmEasy
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Pharmex Direct Inc.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
10.15. Rexall Pharmacy Group ULC.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development